pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-124-1 |
Genomic Coordinates | chr8: 9903388 - 9903472 |
Description | Homo sapiens miR-124-1 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-124-2 |
Genomic Coordinates | chr8: 64379149 - 64379257 |
Description | Homo sapiens miR-124-2 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-124-3 |
Genomic Coordinates | chr20: 63178500 - 63178586 |
Description | Homo sapiens miR-124-3 stem-loop |
Comment | miR-124 was first identified by cloning studies in mouse . The 5' end of the miRNA may be offset with respect to previous annotations. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-124-5p | ||||||||||||||||||||||||||||||
Sequence | 14| CGUGUUCACAGCGGACCUUGAU |35 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NR2E1 | ||||||||||||||||||||
Synonyms | TLL, TLX, XTLL | ||||||||||||||||||||
Description | nuclear receptor subfamily 2 group E member 1 | ||||||||||||||||||||
Transcript | NM_003269 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NR2E1 | |||||||||||||||||||||
3'UTR of NR2E1 (miRNA target sites are highlighted) |
>NR2E1|NM_003269|3'UTR 1 GCTCACAAGATACCCACTTTTCAGGATGGGACAGTATCAGATGAACTTCAACCCATGGAGAACAAGCCTCAACTAACAAA 81 CCCTTCAGGAAGCATATACCGGGGAATGTGTAGCCTTCAGGAAAAAAATGCCAATTGACACAAAGCATTCCAGTAGCTAT 161 GACCTGCCGCCCTGACCAGGATAGGGCGGGTGGGAAGGAGAGGGGTGCAACAGGACCGCCTGCACTGAAAACTCACTGCT 241 GCCATGCCCTGGGAGGGGGCAAACTGGGGGTTGCCACAGGCCGTGCCATTCTGCCTCTTACCTGGAAGATCAGGCTGAAC 321 GATCAAAAGCTGAAACATAAGTAGTGCTTTCTCTTCCTTTTTAGCATACAAAGTTTGGTAACCAAATATAGCTCTGTGTA 401 TAACATCGTACTGCGGCCTTCAAAACTACGTTATGTTGGAGCATTTATTTTAAAAATAATGGTAGGTTTTAAATTAAAAG 481 TGTTATCAAAAGTTTCCCCTCTATTGTAATACATTATTAAGTGGCCTTCAGAACTGAGTTAATAAGTGAAAAGTAGCTTA 561 TGCCATGTGATTTGCTTTTTCTCTATCTTCTTTTTTCTTTTCTTTCTCTTTCTTTTGTTCTTTCTTCTTCTTTTTTAATA 641 CCATAGGCCAGGCAACCTTGTCAAAGGAATTGATGGACAAAATGAGATTCTCACCAGGACTTCAGGTTGGATAACATGTC 721 AAAAAGAGAAGAGCTTTACTAAAAGAACATAAGTCAAGGGAGGATGAATAAAAACAGCAAAACCAAATAAAGTGGAGATG 801 AGTGATTGAGTGAGGTAGATTGCTGTCCCGTTAACATAGTGCTGAAACCAAAGGCAGTGGGGGTCCAAACTCGTGGTGCA 881 GCAAGTCACACCAGACAGGAAACGAATATGGACGTAATTGCAGAAGGAACTTCAAGGAGATGAATGAATGCTAAAAGGGT 961 TCTTGACTGATCCATTGCTAACAGCCTGAGACTCTTCAATGCCTTTCCGAAAACTGGTTTCTAGTAAAGCCTTGAATGAA 1041 CACACACACACACACACACACACACACACACACACACACACACACACACCGTCCTACACTTTAAGCTGCTCCTTTGGTAT 1121 GACTCTATACTTATGGAAATGTAGAAACAAACATTTTTAAATAGCTGCTGTACTTTTCACATTTTGATTTATTAGGTACT 1201 AGCACTGAGGAAAAAAAATTCAGCACTTGGACTATCATAGGATGAGTAAAACTTTTCTTGTACAAAGTGAATTAACTGAT 1281 TTGTGAAGTTAAAAGGTTGTACTCATTGTATTTACAAAGAATAAAAATATATTGAATTTAAATGAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084047. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep4
HITS-CLIP data was present in GSM1084064. RNA binding protein: AGO2. Condition:CLIP_noemetine_AbnovaAb
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
HITS-CLIP data was present in GSM1084077. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_SigmaAb
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1395164. RNA binding protein: AGO. Condition:MCF7 AGO HITS-CLIP Replicate 2
... - Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al., 2014, Breast cancer research and treatment. |
Article |
- Pillai MM; Gillen AE; Yamamoto TM; Kline E; et al. - Breast cancer research and treatment, 2014
miRNAs regulate the expression of genes in both normal physiology and disease. While miRNAs have been demonstrated to play a pivotal role in aspects of cancer biology, these reports have generally focused on the regulation of single genes. Such single-gene approaches have significant limitations, relying on miRNA expression levels and heuristic predictions of mRNA-binding sites. This results in only circumstantial evidence of miRNA-target interaction and typically leads to large numbers of false positive predictions. Here, we used a genome-wide approach (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation, HITS-CLIP) to define direct miRNA-mRNA interactions in three breast cancer subtypes (estrogen receptor positive, Her2 amplified, and triple negative). Focusing on steroid receptor signaling, we identified two novel regulators of the ER pathway (miR-9-5p and miR-193a/b-3p), which together target multiple genes involved in ER signaling. Moreover, this approach enabled the definition of miR-9-5p as a global regulator of steroid receptor signaling in breast cancer. We show that miRNA targets and networks defined by HITS-CLIP under physiologic conditions are predictive of patient outcomes and provide global insight into miRNA regulation in breast cancer.
LinkOut: [PMID: 24906430]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cardiac Tissues |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM2202478. RNA binding protein: AGO2. Condition:S3_LV_36yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202477. RNA binding protein: AGO2. Condition:S2_LV_25yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202479. RNA binding protein: AGO2. Condition:S4_LV_29yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202480. RNA binding protein: AGO2. Condition:S5_LV_36yo_Male_AGO2_bound_RNA
HITS-CLIP data was present in GSM2202481. RNA binding protein: AGO2. Condition:S6_LV_61yo_Male_AGO2_bound_RNA
... - Spengler RM; Zhang X; Cheng C; McLendon JM; et al., 2016, Nucleic acids research. |
Article |
Elucidation of transcriptome-wide microRNA binding sites in human cardiac tissues by Ago2 HITS-CLIP.
- Spengler RM; Zhang X; Cheng C; McLendon JM; et al.- Nucleic acids research, 2016
MicroRNAs (miRs) have emerged as key biological effectors in human health and disease. These small noncoding RNAs are incorporated into Argonaute (Ago) proteins, where they direct post-transcriptional gene silencing via base-pairing with target transcripts. Although miRs have become intriguing biological entities and attractive therapeutic targets, the translational impacts of miR research remain limited by a paucity of empirical miR targeting data, particularly in human primary tissues. Here, to improve our understanding of the diverse roles miRs play in cardiovascular function and disease, we applied high-throughput methods to globally profile miR:target interactions in human heart tissues. We deciphered Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across >2200 target transcripts. Our initial exploration of this interactome revealed an abundance of miR target sites in gene coding regions, including several sites pointing to new miR-29 functions in regulating cardiomyocyte calcium, growth and metabolism. Also, we uncovered several clinically-relevant interactions involving common genetic variants that alter miR targeting events in cardiomyopathy-associated genes. Overall, these data provide a critical resource for bolstering translational miR research in heart, and likely beyond.
LinkOut: [PMID: 27418678]
|
CLIP-seq Support 1 for dataset GSM1084047 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep4 |
Location of target site | ENST00000368986.4 | 3UTR | UGAACACACACACACACACACACACACACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084064 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_AbnovaAb |
Location of target site | ENST00000368986.4 | 3UTR | GAAUGAACACACACACACACACACACACACACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000368986.4 | 3UTR | AAUGAACACACACACACACACACACACACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1084077 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep1_SigmaAb |
Location of target site | ENST00000368986.4 | 3UTR | UGAACACACACACAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000368986.4 | 3UTR | GAAUGAACACACACACACACACACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000368986.4 | 3UTR | UGAACACACACACACACACACAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1395164 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | MCF7 / MCF7 AGO HITS-CLIP Replicate 2 |
Location of target site | ENST00000368986.4 | 3UTR | UGAACACACACACACACACACACACACACACACACACACACACACACACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24906430 / GSE57855 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
65 hsa-miR-124-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT064177 | KIAA1804 | mitogen-activated protein kinase kinase kinase 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT069736 | FOXG1 | forkhead box G1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT086429 | NABP1 | nucleic acid binding protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT105334 | SLC7A2 | solute carrier family 7 member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT110455 | PLEKHA1 | pleckstrin homology domain containing A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT172998 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT196428 | TAOK1 | TAO kinase 1 | ![]() |
![]() |
2 | 14 | ||||||
MIRT325704 | CSTF2 | cleavage stimulation factor subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT365670 | TSC22D3 | TSC22 domain family member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT365873 | XIAP | X-linked inhibitor of apoptosis | ![]() |
![]() |
2 | 2 | ||||||
MIRT404126 | ASB1 | ankyrin repeat and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT404626 | LCOR | ligand dependent nuclear receptor corepressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT405284 | ARF1 | ADP ribosylation factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT406099 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446627 | SDC3 | syndecan 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446906 | RGS5 | regulator of G protein signaling 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461790 | FXR2 | FMR1 autosomal homolog 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463982 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 4 | ||||||
MIRT464204 | VGLL4 | vestigial like family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472790 | MTMR4 | myotubularin related protein 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT473485 | MCFD2 | multiple coagulation factor deficiency 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481124 | AZIN1 | antizyme inhibitor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT485060 | SUCO | SUN domain containing ossification factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT487343 | HLA-DRA | major histocompatibility complex, class II, DR alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT491948 | VPS52 | VPS52, GARP complex subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT497208 | CDH7 | cadherin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497476 | TOR1AIP2 | torsin 1A interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528203 | NELFE | negative elongation factor complex member E | ![]() |
![]() |
2 | 2 | ||||||
MIRT529255 | TRIM4 | tripartite motif containing 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT530096 | PSAPL1 | prosaposin like 1 (gene/pseudogene) | ![]() |
![]() |
2 | 2 | ||||||
MIRT530597 | C7orf33 | chromosome 7 open reading frame 33 | ![]() |
![]() |
2 | 4 | ||||||
MIRT534980 | PSAT1 | phosphoserine aminotransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT538326 | CSGALNACT1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561237 | ZNF652 | zinc finger protein 652 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562035 | KRAS | KRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 2 | ||||||
MIRT563120 | THAP5 | THAP domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563538 | RBM41 | RNA binding motif protein 41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566037 | REV3L | REV3 like, DNA directed polymerase zeta catalytic subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT566505 | PAWR | pro-apoptotic WT1 regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT566745 | MRPL35 | mitochondrial ribosomal protein L35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566850 | LRRC58 | leucine rich repeat containing 58 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568077 | CELF2 | CUGBP Elav-like family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576826 | Tgfbr3 | transforming growth factor, beta receptor III | ![]() |
![]() |
2 | 2 | ||||||
MIRT608870 | NR2E1 | nuclear receptor subfamily 2 group E member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT611997 | VAC14 | Vac14, PIKFYVE complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT614054 | FAM89A | family with sequence similarity 89 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT618800 | SPATA21 | spermatogenesis associated 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619389 | RSPH3 | radial spoke head 3 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT622282 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624026 | EN2 | engrailed homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626000 | MPEG1 | macrophage expressed 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641792 | USP32 | ubiquitin specific peptidase 32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651599 | WDFY2 | WD repeat and FYVE domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659662 | CDC73 | cell division cycle 73 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663010 | KIAA1586 | KIAA1586 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663561 | ASTN2 | astrotactin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669312 | C16orf72 | chromosome 16 open reading frame 72 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685216 | POTED | POTE ankyrin domain family member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT695757 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697909 | TXNRD1 | thioredoxin reductase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707181 | RPH3A | rabphilin 3A | ![]() |
![]() |
2 | 2 | ||||||
MIRT707214 | TRIM13 | tripartite motif containing 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707478 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT719507 | LMAN2L | lectin, mannose binding 2 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT755814 | PARP1 | poly(ADP-ribose) polymerase 1 | 2 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|